Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

The U.S. Food and Drug Administration approved on Thursday a Massachusetts company's request to produce genetically modified salmon.

FDA Grants Approval for Genetically Engineered Salmon

0
Agency says it's safe to eat and doesn't need special label
Narcan (naloxone hydrochloride) nasal spray has been approved by the U.S. Food and Drug Administration to stop or reverse an overdose of opioids.

FDA Approves Narcan Nasal Spray to Counter Opioid Overdose

0
First-of-its-kind drug sanctioned to reverse effects of heroin or oxycodone use
Nearly 2

FDA: Automated Endoscope Reprocessors Recalled

0
Custom Ultrasonics has history of violating federal rules for manufacturing and quality control
Cotellic (cobimetinib) in combination with another chemotherapy

FDA Approves Cotellic for Advanced Melanoma

0
For patients whose tumors express BRAF V600E or V600K mutations
A new treatment for HIV has been approved by the U.S. Food and Drug Administration. Genvoya -- a tablet containing elvitegravir

FDA Approves Genvoya to Treat HIV-1 Infection

0
Medication contains a new form of tenofovir not previously approved by the FDA
The melanoma drug Yervoy (ipilimumab) can now be used to reduce the risk of the recurrence after surgery

FDA Approves Expanded Use for Melanoma Drug

0
Yervoy can now be used after surgery to reduce risk of skin cancer returning
Imlygic (talimogene laherparepvec) has been approved by the U.S. Food and Drug Administration to treat melanoma lesions of the skin and lymph nodes.

FDA Approves Imlygic for Melanoma

0
Injectable drug designed to rupture and kill cancer cells
The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection) to be used in combination with fluorouracil and leucovorin in advanced pancreatic cancer.

FDA Approves Onivyde for Metastatic Pancreatic Cancer

0
To be used in combination with fluorouracil/leucovorin for advanced disease
The chemotherapy drug Yondelis (trabectedin) has been approved by the U.S. Food and Drug Administration to treat certain advanced or unresectable soft-tissue sarcomas.

FDA Approves Yondelis for Soft-Tissue Sarcoma

0
Drug sanctioned for liposarcoma or leiomyosarcoma
Coagadex (coagulation Factor X) has been approved by the U.S. Food and Drug Administration as the first coagulation factor replacement therapy for people with a rare blood disorder known as hereditary Factor X deficiency.

FDA Approves Coagadex for Rare Clotting Disorder

0
First coagulation therapy sanctioned for Factor X deficiency